Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
QGEN.N - Qiagen NV
Qiagen NV at Evercore ISI HealthCONx Conference
Nov 28, 2023 / 05:30PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Company Representative, [1]
--------------------------------------------------------------------------------
(technical difficulty)
there's A, B and C and look at the total cost of ownership to process a test, whether it's HIV, hepatitis C, TB tests or cancer screening, whatever you're trying to get done as a lab, where can I make the highest margin spread in terms of the reimbursement against that business. This is a business that where you have big customers like [QIAseq] LabCorp. You have a lot of regional labs around the world that we're serving. Obviously, our big products here would be QuantiFERON for latent tuberculosis testing. That's approaching $400 million of sales this year. Even though we're barely penetrated only about 35% to 40% penetrated alone in the U.S. on that market. We're also a big player in
Trustpilot
